Verucerfont
Fa'amatalaga Oloa
Faailoga o oloa
| Tele o le afifi | Avanoa | Tau (USD) |
| 100mg | E tele | 700 |
| Tele Tele | Maua Upusii | Maua Upusii |
Igoa vaila'au:
(S) -3-(4-methoxy-2-methylphenyl) -2,5-dimethyl-N-(1-(3-methyl-1,2,4-oxadiazol-5-yl) propyl)pyrazolo[1, 5-a] pyrimidin-7-amine
SMILES Code:
CC[C@H](NC1=CC(C)=NC2=C(C3=CC=C(OC)C=C3C)C(C)=NN12)C4=NC(C)=NO4
InChi Code:
InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14) (4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/ s1
InChi Key:
VKHVAUKFLBBZFJ-SFHVURJKSA-N
upu autu:
Verucerfont, GSK561679, GSK 561679, GSK-561679, NBI77860, NBI 77860, NBI-77860, 885220-61-1
Solubility:Solu i le DMSO
Teuina:0 - 4°C mo taimi pupuu (aso i vaiaso), poo le -20°C mo taimi uumi (masina).
Fa'amatalaga:
"Verucerfont, lea e lauiloa foi o le GSK561679 ma le NBI77860, o se CRF-1 antagonist. Verucerfont poloka le CRH-1 receptor, ma faʻaitiitia ai le faʻamalolo o le ACTH pe a maeʻa le faʻalavelave masani. o se mea e lua i le atinaʻeina o le ava malosi ma le toe faʻaleleia o le ava malosi Ua faʻaalia iʻuga manuia i suʻesuʻega manu ae leʻi faʻataʻitaʻiina tagata."
Sini: CRF-1